Authors: Cooke, SP Boxer, GM Lawrence, L Pedley, RB Spencer, DIR Begent, RHJ Chester, KA

Citation: Sp. Cooke et al., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex, CANCER RES, 61(9), 2001, pp. 3653-3659

Authors: Chester, KA Mayer, A Bhatia, J Robson, L Spencer, DIR Cooke, SP Flynn, AA Sharma, SK Boxer, G Pedley, RB Begent, RHJ

Citation: Ka. Chester et al., Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer, CANC CHEMOT, 46, 2000, pp. S8-S12

Authors: Chester, KA Bhatia, J Boxer, G Cooke, SP Flynn, AA Huhalov, A Mayer, A Pedley, RB Robson, L Sharma, SK Spencer, DIR Begent, RHJ

Citation: Ka. Chester et al., Clinical applications of phage-derived sFvs and sFv fusion proteins, DIS MARKER, 16(1-2), 2000, pp. 53-62

Authors: Spencer, DIR Missailidis, S Denton, G Murray, A Brady, K Matteis, CID Searle, MS Tendler, SJB Price, MR

Citation: Dir. Spencer et al., Structure activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides, BIOSPECTROS, 5(2), 1999, pp. 79-91

Authors: Hinshelwood, J Spencer, DIR Edwards, YJK Perkins, SJ

Citation: J. Hinshelwood et al., Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: Implications for the activity of factor B, J MOL BIOL, 294(2), 1999, pp. 587-599

Authors: Murray, A Spencer, DIR Missailidis, S Denton, G Price, MR

Citation: A. Murray et al., Design of ligands for the purification of anti-MUC1 antibodies by peptide epitope affinity chromatography, J PEPT RES, 52(5), 1998, pp. 375-383